Benchmark and data visualization of Belgian public listed companies in the Healthcare Sector with top companies, stocks performance comparison, distribution of companies across industries, competitive analysis, and comparisons of top companies for market research.
Belgium public listed companies in the Healthcare sector: 10
Belgium Healthcare total companies market cap (USD): $48.62 Billion
 Belgium Analysis
                         Belgium Analysis
                    
                    
                         Top Belgian Companies
                         Top Belgian Companies
                    
                    1-year stock performance comparison (base-100 daily closing prices)
| Industry | Market Cap (USD) | % of Total Market Cap | Number of Companies | % of Total | 
|---|---|---|---|---|
|  Biotechnology | $45.78 B | 94.16% | 4 | 40.00% | 
|  Drug Manufacturers—Specialty & Generic | $1.95 B | 4.02% | 2 | 20.00% | 
|  Medical Devices | $491.9 M | 1.01% | 2 | 20.00% | 
|  Medical Instruments & Supplies | $295.2 M | 0.61% | 1 | 10.00% | 
|  Diagnostics & Research | $96.6 M | 0.20% | 1 | 10.00% | 
|  Drug Manufacturers—General | $0 | 0.00% | 0 | 0.00% | 
|  Healthcare Plans | $0 | 0.00% | 0 | 0.00% | 
|  Health Information Services | $0 | 0.00% | 0 | 0.00% | 
|  Medical Care Facilities | $0 | 0.00% | 0 | 0.00% | 
|  Medical Distribution | $0 | 0.00% | 0 | 0.00% | 
|  Pharmaceutical Retailers | $0 | 0.00% | 0 | 0.00% | 
| Total | $48.62 B | 100% | 10 | 100% | 
| Company | Market Cap (USD) | Country | Sector | Industry | 
|---|---|---|---|---|
| UCB SA | $36.93 B |  Belgium |  Healthcare |  Biotechnology | 
| Financière de Tubize SA | $6.93 B |  Belgium |  Healthcare |  Biotechnology | 
| Fagron NV | $1.94 B |  Belgium |  Healthcare |  Drug Manufacturers—Specialty & Generic | 
| Galapagos NV | $1.91 B |  Belgium |  Healthcare |  Biotechnology | 
| Ion Beam Applications SA | $393.3 M |  Belgium |  Healthcare |  Medical Devices | 
| Nyxoah SA | $295.2 M |  Belgium |  Healthcare |  Medical Instruments & Supplies | 
| Sequana Medical NV | $98.6 M |  Belgium |  Healthcare |  Medical Devices | 
| MDxHealth SA | $96.6 M (July 1, 2023) |  Belgium |  Healthcare |  Diagnostics & Research | 
| Mithra Pharmaceuticals SA | $15.5 M (July 1, 2024) |  Belgium |  Healthcare |  Drug Manufacturers—Specialty & Generic | 
| Celyad Oncology SA | $14.2 M (July 1, 2023) |  Belgium |  Healthcare |  Biotechnology |